lupus erythematosus

Correspondence on ‘NCF1-339 polymorphism is associated with altered formation of neutrophil extracellular traps, high serum interferon activity and antiphospholipid syndrome in systemic lupus erythematosus’ by Linge et al
George N Goulielmos, Maria I Zervou, Elias Eliopoulos

Annals of the Rheumatic Diseases Dec 2023, 82 (12) e231; DOI: 10.1136/annrheumdis-2021-221871
Correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine’
Hercílio Martelli Júnior, Nelson Pereira Marques, Nádia Carolina Teixeira Marques, Edson Gomes de Lucena, Daniella Reis B Martelli, Eduardo A Oliveira

Annals of the Rheumatic Diseases Nov 2023, 82 (11) e224; DOI: 10.1136/annrheumdis-2021-220410
Correspondence on “New EULAR/ACR 2019 SLE classification criteria: defining ominosity in SLE”
Guillermo J Pons-Estel, Manuel F. Ugarte-Gil, Guillermina B Harvey, Bernardo A Pons-Estel, Graciela S Alarcón

Annals of the Rheumatic Diseases Aug 2023, 82 (8) e189; DOI: 10.1136/annrheumdis-2021-220994
Response to: Correspondence on “New EULAR/ACR 2019 SLE classification criteria: defining ominosity in SLE” by Pons-Estel et al
Laura Whittall-Garcia, Dafna D Gladman, Murray Urowitz, Jiandong Su, Zahi Touma, Sindhu R Johnson

Annals of the Rheumatic Diseases Aug 2023, 82 (8) e190; DOI: 10.1136/annrheumdis-2021-221014
Correspondence on “Update on the diagnosis and management of systemic lupus erythematosus”
Zhuochao Zhou, Yijun You, Fan Wang, Yue Sun, Jialin Teng, Honglei Liu, Xiaobing Cheng, Yutong Su, Hui Shi, Chengde Yang, Junna Ye

Annals of the Rheumatic Diseases Aug 2023, 82 (8) e191; DOI: 10.1136/annrheumdis-2021-220897
Response to: Correspondence on “Update on the diagnosis and management of systemic lupus erythematosus” by Zhou et al
Antonis Fanouriakis, Nikolaos Tziolos, George Bertsias, Dimitrios T Boumpas

Annals of the Rheumatic Diseases Aug 2023, 82 (8) e192; DOI: 10.1136/annrheumdis-2021-221151
Response to: Correspondence on “European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance” by Bossuyt et al
Martin Aringer, Karen Costenbader, Nicolai Leuchten, Thomas Dörner, Sindhu R Johnson

Annals of the Rheumatic Diseases Aug 2023, 82 (8) e194; DOI: 10.1136/annrheumdis-2021-221374
Correspondence on ‘Call for action in ANCA-associated vasculitis and lupus nephritis: promises and challenges of SGLT-2 inhibitors’
Dimitrios Patoulias

Annals of the Rheumatic Diseases Aug 2023, 82 (8) e195; DOI: 10.1136/annrheumdis-2021-221953
Correspondence on ‘Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine-learning-based model to assist the diagnosis of systemic lupus erythematosus’
Ezgi Deniz Batu, Ummusen Kaya Akca, Ozge Basaran, Yelda Bilginer, Seza Ozen

Annals of the Rheumatic Diseases Jun 2023, 82 (6) e144; DOI: 10.1136/annrheumdis-2021-220246
Response to: ‘Correspondence on ‘Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus’ by Batu et al
Christina Adamichou, George Bertsias

Annals of the Rheumatic Diseases Jun 2023, 82 (6) e145; DOI: 10.1136/annrheumdis-2021-220262

Main menu

lupus erythematosus

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

lupus erythematosus

Pages